Why the study?
Does the size of the 4q35-associated deletion correlate with disease severity in Facioscapulohumeral muscular dystrophy, and is there evidence of genetic anticipation?
Does the size of the 4q35-associated deletion correlate with disease severity in Facioscapulohumeral muscular dystrophy, and is there evidence of genetic anticipation?
Disease severity in Facioscapulohumeral muscular dystrophy strongly correlates with the size of the 4q35-associated deletion, and generational worsening suggests genetic anticipation.
Answers are grounded in this paper and cite their sources.
May inform genetic counseling on FSHD severity; leaves open prospective validation of anticipation.
Facioscapulohumeral muscular dystrophy (FSHD) is characterized by marked inter- and intrafamilial heterogeneity in its clinical expression. The contribution of genetic factors to this variability is not well characterized. We examined the relationship of phenotype to genotype in a clinically and genetically well-defined FSHD population. Quantitative isometric myometry (QMT) scores, normalized for age, gender, and height, were used to quantify disease severity. We found a significant (r = 0.92, p < 0.004) correlation between disease severity and the size of the 4q35-associated deletion. In addition, when relative disease severity of parent-offspring pairs was compared, the offspring were found to be significantly more severely affected (p = 0.011). This generational effect suggests the presence of anticipation in FSHD and raises the possibility of an underlying dynamic mutation.
No takes yet. Share an insight, caveat, or question.
Tawil et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: